YUFLYMA Trademark

Trademark Overview

On Wednesday, August 7, 2019, a trademark application was filed for YUFLYMA with the United States Patent and Trademark Office. The USPTO has given the YUFLYMA trademark a serial number of 79268175. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, June 9, 2026. This trademark is owned by CELLTRION, INC.. The YUFLYMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases
yuflyma

General Information

Serial Number79268175
Word MarkYUFLYMA
Filing DateWednesday, August 7, 2019
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, June 9, 2026
Registration Number5999367
Registration DateTuesday, March 3, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELLTRION, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIncheon 22014
KR
Party NameCELLTRION, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameCELLTRION, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Thursday, September 26, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 8, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, November 5, 2019ASSIGNED TO EXAMINER
Thursday, November 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2019NOTICE OF PUBLICATION
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 3, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, April 2, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, April 17, 2020FINAL DISPOSITION PROCESSED
Friday, April 17, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 8, 2020NOTIFICATION PROCESSED BY IB
Friday, February 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, February 4, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 4, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 4, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 4, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 4, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 4, 2026TEAS SECTION 71 & 15 RECEIVED
Monday, June 1, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 9, 2026REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, June 9, 2026NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Related Keywords

yuflyma diseases autoimmune treatment preparations pharmaceutical